Health Services Research
Latest posts by Health Services Research (see all)
- Young Adult Dependent Coverage: Were the State Reforms Effective? - Aug. 20, 2014
- The Patterns of Health Care Utilization by Elderly Europeans: Frailty and Its Implications for… - Aug. 19, 2014
- Estimating Premium Sensitivity for Children’s Public Health Insurance Coverage: Selection but… - Aug. 15, 2014
- Impact of a Pharmacy Benefit Change on New Use of Mail Order Pharmacy among Diabetes Patients:… - Aug. 15, 2014
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.